Thomas Jenuwein
PhD
Director
👥Biography 个人简介
Thomas Jenuwein co-discovered the first histone lysine methyltransferase SUV39H1, demonstrating that histone H3K9 methylation recruits heterochromatin protein 1 (HP1) to establish constitutive heterochromatin, a discovery that opened the entire field of histone methylation enzymology. His work showed that loss of H3K9me3 and heterochromatin destabilization causes genomic instability through derepression of pericentromeric satellite repeats and transposable elements, contributing to chromosome segregation errors and cancer predisposition. He has established that H3K9 methylation safeguards genome integrity by maintaining repeat element silencing. His conceptual and experimental contributions to histone methylation biology earned him the Gruber Prize in Genetics.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thomas Jenuwein 的研究动态
Follow Thomas Jenuwein's research updates
留下邮箱,当我们发布与 Thomas Jenuwein(Max Planck Institute of Immunobiology and Epigenetics)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment